Related references
Note: Only part of the references are listed.Nutlin-3 enhances sorafenib efficacy in renal cell carcinoma
Rit Vatsyayan et al.
MOLECULAR CARCINOGENESIS (2013)
Pleiotropic Action of Renal Cell Carcinoma-Dysregulated miRNAs on Hypoxia-Related Signaling Pathways
Zsuzsanna Lichner et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Combined p53 and MDM2 biomarker analysis shows a unique pattern of expression associated with poor prognosis in patients with renal cell carcinoma undergoing radical nephrectomy
Aidan P. Noon et al.
BJU INTERNATIONAL (2012)
miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms
Upeka Senanayake et al.
CARCINOGENESIS (2012)
Aberrant expression of cell cycle regulatory genes predicts overall and disease free survival in malignant pleural mesothelioma patients
Abeer A. Bahnassy et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2012)
Modulation of MicroRNA-194 and Cell Migration by HER2-Targeting Trastuzumab in Breast Cancer
Xiao-Feng Le et al.
PLOS ONE (2012)
Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses
Heba W. Z. Khella et al.
TUMOR BIOLOGY (2012)
Reference genes for the relative quantification of microRNAs in renal cell carcinomas and their metastases
Zofia Wotschofsky et al.
ANALYTICAL BIOCHEMISTRY (2011)
Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma
Danielle M. Patterson et al.
ANGIOGENESIS (2011)
MicroRNAs and their target gene networks in renal cell carcinoma
Martina Redova et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Regulatory coordination of clustered microRNAs based on microRNA-transcription factor regulatory network
Jin Wang et al.
BMC SYSTEMS BIOLOGY (2011)
miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215
N. M. A. White et al.
BRITISH JOURNAL OF CANCER (2011)
MicroRNAs as new therapeutic targets and tools in cancer
Paolo Gandellini et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Translating Molecular Signatures of Renal Cell Carcinoma into Clinical Practice
Nicole M. A. White et al.
JOURNAL OF UROLOGY (2011)
miRNA Profiling for Clear Cell Renal Cell Carcinoma: Biomarker Discovery and Identification of Potential Controls and Consequences of miRNA Dysregulation
Nicole M. A. White et al.
JOURNAL OF UROLOGY (2011)
MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1
Peixin Dong et al.
MOLECULAR CANCER (2011)
Metastamirs: a stepping stone towards improved cancer management
Nicole M. A. White et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
A Perspective on Cancer Cell Metastasis
Christine L. Chaffer et al.
SCIENCE (2011)
MDM2 gene amplification and protein expressions in colon carcinoma: is targeting MDM2 a new therapeutic option?
Monirath Hav et al.
VIRCHOWS ARCHIV (2011)
Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma
Joana Heinzelmann et al.
WORLD JOURNAL OF UROLOGY (2011)
Dysregulation of kallikrein-related peptidases in renal cell carcinoma: potential targets of miRNAs
Nicole M. White et al.
BIOLOGICAL CHEMISTRY (2010)
MicroRNAs: exploring a new dimension in the pathogenesis of kidney cancer
Nicole M. A. White et al.
BMC MEDICINE (2010)
Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer
N. M. A. White et al.
BRITISH JOURNAL OF CANCER (2010)
p53 and MDM2 in Renal Cell Carcinoma Biomarkers for Disease Progression and Future Therapeutic Targets?
Aidan P. Noon et al.
CANCER (2010)
被撤回的出版物: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development (Retracted article. See vol. 40, pg. 1442, 2022)
Flavia Pichiorri et al.
CANCER CELL (2010)
MDM2 promotes cell motility and invasiveness through a RING-finger independent mechanism
Radoslaw Polanski et al.
FEBS LETTERS (2010)
miR-194 Is a Marker of Hepatic Epithelial Cells and Suppresses Metastasis of Liver Cancer Cells in Mice
Zhipeng Meng et al.
HEPATOLOGY (2010)
The miR-17-92 Cluster is Over Expressed in and Has an Oncogenic Effect on Renal Cell Carcinoma
Tsz-fung F. Chow et al.
JOURNAL OF UROLOGY (2010)
miR-192/miR-215 Influence 5-Fluorouracil Resistance through Cell Cycle-Mediated Mechanisms Complementary to Its Post-transcriptional Thymidilate Synthase Regulation
Valentina Boni et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Epidemiology and risk factors for kidney cancer
Wong-Ho Chow et al.
NATURE REVIEWS UROLOGY (2010)
Clustered microRNAs' coordination in regulating protein-protein interaction network
Xiongying Yuan et al.
BMC SYSTEMS BIOLOGY (2009)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
MicroRNAs and the kidney: coming of age
Samuel Saal et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2009)
Rising incidence of renal cell carcinoma in Ireland
Opeyemi A. Falebita et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2009)
MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy
Monika Jung et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
MicroRNAs in clinical oncology: at the crossroads between promises and problems
S. M. Metias et al.
JOURNAL OF CLINICAL PATHOLOGY (2009)
Small but influential: the role of microRNAs on gene regulatory network and 3 ' UTR evolution
Rui Zhang et al.
JOURNAL OF GENETICS AND GENOMICS (2009)
Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell
Georgia Sotiropoulou et al.
RNA (2009)
p53-Responsive MicroRNAs 192 and 215 Are Capable of Inducing Cell Cycle Arrest
Christian J. Braun et al.
CANCER RESEARCH (2008)
Folate metabolism genes, vegetable intake and renal cancer risk in central Europe
Lee E. Moore et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma
Hiroshi Hirata et al.
CLINICAL CANCER RESEARCH (2007)
Molecular characterization of the human common fragile site FRAIH
Angela Curatolo et al.
GENES CHROMOSOMES & CANCER (2007)
MDM2 promotes cell motility and invasiveness by regulating E-cadherin degradation
Jer-Yen Yang et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B
B Krishnamachary et al.
CANCER RESEARCH (2006)
Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients
TL Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization
RL Camp et al.
CLINICAL CANCER RESEARCH (2004)
Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs
YQ Sun et al.
NUCLEIC ACIDS RESEARCH (2004)
Share Paper
